SPIROLIGOMER Trademark
Trademark Overview
On Monday, July 24, 2023, a trademark application was filed for SPIROLIGOMER with the United States Patent and Trademark Office. The USPTO has given the SPIROLIGOMER trademark a serial number of 98098485. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, November 14, 2024. This trademark is owned by ThirdLaw Molecular LLC. The SPIROLIGOMER trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Manufacturing of synthetic, biologically active, macromolecules for others; Manufacturing of pharmaceuticals and chemicals for others
Pharmaceutical products for use in oncology; Pharmaceutical products for use in dermatology treatments; pharmaceutical products for use in treatment of metabolic, cardiovascular, central nervous system, hematologic, respiratory, immunologic, inflammatory, gastrointestinal, and infectious diseases; pharmaceutical preparations for use as diagnostics
Scientific research; biomedical research services; scientific study and research in the field of the development of future medical treatments in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; laboratory research services in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; providing information, consultancy and advisory services relating to the design, planning and implementation of scientific and clinical research for others
General Information
Serial Number | 98098485 |
Word Mark | SPIROLIGOMER |
Filing Date | Monday, July 24, 2023 |
Status | 680 - APPROVED FOR PUBLICATION |
Status Date | Thursday, November 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Manufacturing of synthetic, biologically active, macromolecules for others; Manufacturing of pharmaceuticals and chemicals for others |
Goods and Services | Pharmaceutical products for use in oncology; Pharmaceutical products for use in dermatology treatments; pharmaceutical products for use in treatment of metabolic, cardiovascular, central nervous system, hematologic, respiratory, immunologic, inflammatory, gastrointestinal, and infectious diseases; pharmaceutical preparations for use as diagnostics |
Goods and Services | Scientific research; biomedical research services; scientific study and research in the field of the development of future medical treatments in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; laboratory research services in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; providing information, consultancy and advisory services relating to the design, planning and implementation of scientific and clinical research for others |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 22, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 22, 2023 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 22, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | ThirdLaw Molecular LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Blue Bell, PA 19422 |
Trademark Events
Event Date | Event Description |
Tuesday, August 22, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, March 26, 2024 | ASSIGNED TO EXAMINER |
Thursday, April 4, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, April 4, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, April 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 24, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Thursday, July 27, 2023 | NEW APPLICATION ENTERED |
Monday, June 24, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Friday, October 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, October 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, October 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, November 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |